Vrozené srdeční vady u dospělých

Jana Popelová

Interv Akut Kardiol. 2011;10(4):152-153  

Endovascular treatment of the thoracic aorta emergencies: long term follow-up

Jan Raupach, Jan Vojáček, Miroslav Lojík, Antonín Krajina, Josef Bis, Vendelín Chovanec, Jan Harrer, Martin Tuna, Radovan Malý

Interv Akut Kardiol. 2011;10(4):154-162  

Purpose: Retrospective analysis of efficacy and safety of endovascular treatment of diseases of the descending thoracic aorta and distal aortic arch with thoracic stent-graft. Material and Methods: From May 1999 to March 2011 we treated 62 patients (46 men, 16 women, mean age 59.5 years). These were symptomatic degenerative aneurysms (n = 7), penetrating aortic ulcers (n = 7), mycotic aneurysms (n = 4), type B aortic dissections (n = 20), traumatic aortic injuries (n = 24). For a short proximal anchoring zone in 3 patients we used a hybrid approach with surgical rerouting technique and then stent-grafting. A total of 62 patients, we introduced...

The present state and results of the transcatheter aortic valve implantation

Michael Želízko

Interv Akut Kardiol. 2011;10(4):164-168  

An overview article of transcatheter aortic valve implantation. Indications, mid-term results of the PARTNER trial and possible complications are described.

Prevention of infective endocarditis

Radek Pelouch

Interv Akut Kardiol. 2011;10(4):170-174  

Infective endocarditis (IE) is a severe disease. It is known, that some underlying cardiac conditions are associated with the risk of acquisition of IE. Transient bacteremia is commonly associated with some medical procedures. Antibiotic prophylaxis has been recommended before them, although valid data supporting this practise does not exist. Vice versa bacteremia is much more frequently associated with routine daily activities (tooth brushing, chewing food, flossing). Accordingly, recently published foreign guidelines recommend to reduce prophylactic antibiotics use. Administration of antibiotic prophylaxis is now recommended only for patients...

Thrombembolic and bleeding complications in heart valve prosthesis holders

Jaroslav Dušek, Miroslav Brtko, Josef Šťásek, Josef Bis, Jan Vojáček, Pavel Polanský, Dušan Černohorský

Interv Akut Kardiol. 2011;10(4):176-181  

Many complications may occur in patients with heart valve replacement. The thrombembolic and bleeding complications are the most considerable. Choosing between the mechanic and biological valve prosthesis is very important due to many reasons. In case of mechanical valve prosthesis we can expect life long good function of the prosthesis at the expense of higher thrombembolic and bleeding complications. The incidence of mechanical valve prosthesis thrombosis is in the range 0.2–1.8 %/patient/year. The treatment depends on patient´s condition and presence of valve prosthesis obstruction. Reoperation, thrombolysis or anticoagulation therapy...

Is dabigatran a true alternative in preventing thromboembolic complications in patients with atrial fibrillation ?

Kateřina Lefflerová

Interv Akut Kardiol. 2011;10(4):182-186  

Prevention of thromboembolic complications in patients with atrial fibrillation represents a key therapeutic goal in the care of patients with this arrhythmia. Anticoagulation therapy with warfarin is capable of reducing the risk of stroke by 64 %. However, treatment with warfarin is associated with a number of disadvantages, and thus only a portion of patients are treated and not all achieve the therapeutic range. Dabigatran is a direct thrombin inhibitor administered orally at a fixed dose without a need for monitoring the anticoagulant effect. Its safety and efficacy in preventing stroke and systemic embolization in patients with atrial...

Tako-tsubo cardiomyopathy presenting after delivery

Robert Náplava, Zdeněk Coufal, Martin Gřiva, Jerguš Mistrík, Dagmar Vlčková

Interv Akut Kardiol. 2011;10(4):192-193  

Case report presents a midventricular form of Tako-tsubo cardiomyopathy after normal spontaneous vaginal delivery in young women.

Medical treatment in coincident valvular heart disease and arterial hypertension

Zdeněk Monhart, Václav Monhart

Interv Akut Kardiol. 2011;10(4):187-190  

Causal therapy of valvular heart disease falls within the realm of cardiac surgery. A number of patients with valvular heart disease concurrently suffer from arterial hypertension – they are either patients with a defect that has not yet been indicated for surgery or those in whom a conservative approach has been chosen due to high surgical risk. When treating arterial hypertension in these patients, it is often possible to select antihypertensive agents with a certain „added value“ in terms of affecting the symptoms of valvular disease and left ventricular volumes. These include, in particular, ACE inhibitors in aortic and...

Nová strategie záchovných operací aortální chlopně: sympozium Aortic Valve Repair: A Step by Step Approach, Paříž 2011

Pavel Žáček

Interv Akut Kardiol. 2011;10(4):195  

Akutní kardiologie na sjezdu ČKS v roce 2011

Tomáš Janota

Interv Akut Kardiol. 2011;10(4):196  

Intervenční kardiologie - zpráva z XIX. výročního sjezdu ČKS

Petr Kala, Martin Mates

Interv Akut Kardiol. 2011;10(4):197  

Aktivity Pracovní skupiny pro arytmie a kardiostimulaci

Robert Čihák

Interv Akut Kardiol. 2011;10(4):198